Alzheon

Framingham, Massachusetts biopharmaceutical company working on treatments for Alzheimer's disease.

View on the globe

$78.8MEquity raised in 2025–20262025 — · 2026 $78.8M · 1 equity round
$78.8MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 26 Aug 2026 to 26 Aug 2026, $78.8M equity disclosed. Earlier rounds exist but are not sourced.26 Aug 2026: Form D offering (series not named), $78.8M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourced2026Q2Q3Q42027Q2Equity round26 Aug 2026 · Form D offering (series not named) · $78.8MOther · $78.8M
Funding history: 1 round from 26 Aug 2026 to 26 Aug 2026, $78.8M equity disclosed. Earlier rounds exist but are not sourced.26 Aug 2026: Form D offering (series not named), $78.8M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ2Q3Q42027Q2Equity round26 Aug 2026 · Form D offering (series not named) · $78.8M$78.8M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Alzheon raised before 26 Aug 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Form D offering (series not named)
    Amount$78.8M
    Post-money—
    ✓ Confirmed
    Note
    SEC Form D: $78,797,184 sold against a $499,999,999 offering, first sale 2026-08-26, filed 2026-09-10; 3 investors reported (names not in the parts read). The filing does not name a series, so stage is other. Series F label and $1.3B valuation come from Multiples.vc (not acceptable) and are left out. No valuation in the filing. Form D/A filed 2025-02-10 (first sale 2024-02-27, USD 126,259,938 sold, 76 investors) is a 2024-origin offering, outside the window: not added. A June 2024 Series E ($100M) seen in search results only (not opened): outside the window, not added.
    Sources
  2. Earlier rounds not yet sourced

Also in the Framingham hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Alzheon and its logo are trademarks of their owners, used here for identification only.